Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02840851 · ClinicalTrials.gov registry record
Brain Blood Flow: Age and Gender
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 46
- Enrollment target
NCT02840851: Completed study, sponsored by University of Wisconsin, Madison.
NCT02840851 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02840851 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
Baseline cerebral blood flow through the middle cerebral artery (MCA) and cerebral vasodilator response of the MCA to inhaled carbon dioxide (CO2) will be measured in young women, young men, older women, and older men using Magnetic Resonance (MR) imaging and transcranial Doppler ultrasound (TCD). Data collection techniques will be compared.
Primary Outcome
Utilize the TCD and MR imaging to measure middle cerebral artery blood flow in the brain while the participant is at rest.
Interventions
- DEVICE MRI
- DEVICE TCD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2016-11 |
| Est. Completion | 2018-09 |
What the finished NCT02840851 record still lists
NCT02840851 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.
NCT02840851 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02840851 about?
NCT02840851 is a clinical study titled "Brain Blood Flow: Age and Gender". Baseline cerebral blood flow through the middle cerebral artery (MCA) and cerebral vasodilator response of the MCA to inhaled carbon dioxide (CO2) will be measured in young women, young men, older women, and older men using Magnetic Resonance (MR) imaging and transcranial Doppler ultrasound (TCD). D...
What is the current status of trial NCT02840851?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2016-11. Estimated completion is 2018-09.
What interventions are being tested in trial NCT02840851?
The interventions under investigation include: MRI (DEVICE), TCD (DEVICE).
Who is sponsoring clinical trial NCT02840851?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia